These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 25239189)

  • 21. Sequential distribution of pTDP-43 pathology in behavioral variant frontotemporal dementia (bvFTD).
    Brettschneider J; Del Tredici K; Irwin DJ; Grossman M; Robinson JL; Toledo JB; Fang L; Van Deerlin VM; Ludolph AC; Lee VM; Braak H; Trojanowski JQ
    Acta Neuropathol; 2014 Mar; 127(3):423-439. PubMed ID: 24407427
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of TDP-43 seeding activity in the olfactory mucosa from patients with frontotemporal dementia.
    Fontana E; Bongianni M; Benussi A; Bronzato E; Scialo C; Sacchetto L; Cagnin A; Castriciano S; Buratti E; Gardoni F; Italia M; Schreiber A; Ferracin C; Fiorini M; Newell KL; Cracco L; Garringer HJ; Cecchini MP; Polymenidou M; Padovani A; Monaco S; Legname G; Ghetti B; Borroni B; Zanusso G
    Alzheimers Dement; 2024 Feb; 20(2):1156-1165. PubMed ID: 37908186
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuronal cytoplasmic inclusions in tau, TDP-43, and FUS molecular subtypes of frontotemporal lobar degeneration share similar spatial patterns.
    A Armstrong R
    Folia Neuropathol; 2017; 55(3):185-192. PubMed ID: 28984110
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lower motor neuron involvement in TAR DNA-binding protein of 43 kDa-related frontotemporal lobar degeneration and amyotrophic lateral sclerosis.
    Riku Y; Watanabe H; Yoshida M; Tatsumi S; Mimuro M; Iwasaki Y; Katsuno M; Iguchi Y; Masuda M; Senda J; Ishigaki S; Udagawa T; Sobue G
    JAMA Neurol; 2014 Feb; 71(2):172-9. PubMed ID: 24378564
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Neuropathology of frontotemporal lobar degeneration with ubiquitinated inclusions].
    Yoshida M
    Brain Nerve; 2009 Nov; 61(11):1308-18. PubMed ID: 19938688
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A morphometric study of the spatial patterns of TDP-43 immunoreactive neuronal inclusions in frontotemporal lobar degeneration (FTLD) with progranulin (GRN) mutation.
    Armstrong RA; Cairns NJ
    Histol Histopathol; 2011 Feb; 26(2):185-90. PubMed ID: 21154232
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pattern of ubiquilin pathology in ALS and FTLD indicates presence of C9ORF72 hexanucleotide expansion.
    Brettschneider J; Van Deerlin VM; Robinson JL; Kwong L; Lee EB; Ali YO; Safren N; Monteiro MJ; Toledo JB; Elman L; McCluskey L; Irwin DJ; Grossman M; Molina-Porcel L; Lee VM; Trojanowski JQ
    Acta Neuropathol; 2012 Jun; 123(6):825-39. PubMed ID: 22426854
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heterogeneous ribonuclear protein A3 (hnRNP A3) is present in dipeptide repeat protein containing inclusions in Frontotemporal Lobar Degeneration and Motor Neurone disease associated with expansions in C9orf72 gene.
    Davidson YS; Flood L; Robinson AC; Nihei Y; Mori K; Rollinson S; Richardson A; Benson BC; Jones M; Snowden JS; Pickering-Brown S; Haass C; Lashley T; Mann DMA
    Acta Neuropathol Commun; 2017 Apr; 5(1):31. PubMed ID: 28431575
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Possible concurrence of TDP-43, tau and other proteins in amyotrophic lateral sclerosis/frontotemporal lobar degeneration.
    Takeda T
    Neuropathology; 2018 Feb; 38(1):72-81. PubMed ID: 28960544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Severe subcortical TDP-43 pathology in sporadic frontotemporal lobar degeneration with motor neuron disease.
    Brandmeir NJ; Geser F; Kwong LK; Zimmerman E; Qian J; Lee VM; Trojanowski JQ
    Acta Neuropathol; 2008 Jan; 115(1):123-31. PubMed ID: 18004574
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phosphorylated and cleaved TDP-43 in ALS, FTLD and other neurodegenerative disorders and in cellular models of TDP-43 proteinopathy.
    Arai T; Hasegawa M; Nonoka T; Kametani F; Yamashita M; Hosokawa M; Niizato K; Tsuchiya K; Kobayashi Z; Ikeda K; Yoshida M; Onaya M; Fujishiro H; Akiyama H
    Neuropathology; 2010 Apr; 30(2):170-81. PubMed ID: 20102522
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TDP-43 variants of frontotemporal lobar degeneration.
    Bigio EH
    J Mol Neurosci; 2011 Nov; 45(3):390-401. PubMed ID: 21607722
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Limbic-predominant age-related TDP-43 encephalopathy differs from frontotemporal lobar degeneration.
    Robinson JL; Porta S; Garrett FG; Zhang P; Xie SX; Suh E; Van Deerlin VM; Abner EL; Jicha GA; Barber JM; Lee VM; Lee EB; Trojanowski JQ; Nelson PT
    Brain; 2020 Sep; 143(9):2844-2857. PubMed ID: 32830216
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Laminar distribution of the pathological changes in sporadic frontotemporal lobar degeneration with transactive response (TAR) DNA-binding protein of 43 kDa (TDP-43) proteinopathy: a quantitative study using polynomial curve fitting.
    Armstrong RA; Hamilton RL; Mackenzie IR; Hedreen J; Cairns NJ
    Neuropathol Appl Neurobiol; 2013 Jun; 39(4):335-47. PubMed ID: 22804696
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TDP-43 subtypes are associated with distinct atrophy patterns in frontotemporal dementia.
    Rohrer JD; Geser F; Zhou J; Gennatas ED; Sidhu M; Trojanowski JQ; Dearmond SJ; Miller BL; Seeley WW
    Neurology; 2010 Dec; 75(24):2204-11. PubMed ID: 21172843
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of TMEM106B, the frontotemporal lobar degeneration-associated protein, in normal and diseased human brain.
    Busch JI; Martinez-Lage M; Ashbridge E; Grossman M; Van Deerlin VM; Hu F; Lee VM; Trojanowski JQ; Chen-Plotkin AS
    Acta Neuropathol Commun; 2013 Jul; 1():36. PubMed ID: 24252750
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ubiquitinated pathological lesions in frontotemporal lobar degeneration contain the TAR DNA-binding protein, TDP-43.
    Davidson Y; Kelley T; Mackenzie IR; Pickering-Brown S; Du Plessis D; Neary D; Snowden JS; Mann DM
    Acta Neuropathol; 2007 May; 113(5):521-33. PubMed ID: 17219193
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TDP-43 extracted from frontotemporal lobar degeneration subject brains displays distinct aggregate assemblies and neurotoxic effects reflecting disease progression rates.
    Laferrière F; Maniecka Z; Pérez-Berlanga M; Hruska-Plochan M; Gilhespy L; Hock EM; Wagner U; Afroz T; Boersema PJ; Barmettler G; Foti SC; Asi YT; Isaacs AM; Al-Amoudi A; Lewis A; Stahlberg H; Ravits J; De Giorgi F; Ichas F; Bezard E; Picotti P; Lashley T; Polymenidou M
    Nat Neurosci; 2019 Jan; 22(1):65-77. PubMed ID: 30559480
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Concomitant TAR-DNA-binding protein 43 pathology is present in Alzheimer disease and corticobasal degeneration but not in other tauopathies.
    Uryu K; Nakashima-Yasuda H; Forman MS; Kwong LK; Clark CM; Grossman M; Miller BL; Kretzschmar HA; Lee VM; Trojanowski JQ; Neumann M
    J Neuropathol Exp Neurol; 2008 Jun; 67(6):555-64. PubMed ID: 18520774
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tau pathology in frontotemporal lobar degeneration with C9ORF72 hexanucleotide repeat expansion.
    Bieniek KF; Murray ME; Rutherford NJ; Castanedes-Casey M; DeJesus-Hernandez M; Liesinger AM; Baker MC; Boylan KB; Rademakers R; Dickson DW
    Acta Neuropathol; 2013 Feb; 125(2):289-302. PubMed ID: 23053135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.